CervoMed Inc. Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost
CervoMed Inc. (CRVO) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost of $977.32 thousand as of 2025-12-31, per its 10-K filed 2026-03-13.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost · last filed 2026-03-13
- 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $977.32K.
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $698.89K.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $567.47K.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $514.65K; Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost as first filed $1.75M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost as first filed |
|---|---|---|
| 2025-12-31 | $977.32K 10-K · filed 2026-03-13 | |
| 2024-12-31 | $698.89K 10-K · filed 2026-03-13 | |
| 2023-12-31 | $567.47K 10-K · filed 2025-03-17 | |
| 2022-12-31 | $514.65K 10-K · filed 2024-03-29 | $1.75M 10-K · filed 2023-03-24 |
| 2021-12-31 | $1.64M 10-K · filed 2023-03-24 | |
| 2020-12-31 | $1.57M 10-K · filed 2022-03-18 | |
| 2019-12-31 | $1.38M 10-K · filed 2021-03-17 | |
| 2018-12-31 | $2.46M 10-K · filed 2020-03-17 | |
| 2017-12-31 | $2.14M 10-K · filed 2019-03-19 | |
| 2016-12-31 | $2.72M 10-K · filed 2018-04-02 | |
| 2015-12-31 | $6.94M 10-K · filed 2016-03-25 | |
| 2014-12-31 | $6.08M 10-K · filed 2016-03-25 | |
| 2013-12-31 | $5.84M 10-K · filed 2015-04-03 | |
| 2012-12-31 | $904.33K 10-K/A · filed 2014-04-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |